Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
Clinical trial NCT07280702 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07280702
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-15
- Primary completion
- 2027-12-15
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.